Tatyana A. Prokhorova

Tatyana A. Prokhorova

Auto-generated profile, based on publicly available information

Tatyana A. Prokhorova

Russian Mental Health Research Centre

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2014 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
GBG. Sh. Burbaeva
G. Sh. Burbaeva
IBI. S. Boksha
I. S. Boksha
ETE. B. Tereshkina
E. B. Tereshkina
OSO. K. Savushkina
O. K. Savushkina
TPT. A. Prokhorova
T. A. Prokhorova
EVE. A. Vorobyeva
E. A. Vorobyeva

1 January 2016 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
ТPТ А Prokhorova
Т А Prokhorova
IBI S Boksha
I S Boksha
OSO K Savushkina
O K Savushkina
ETE B Tereshkina
E B Tereshkina
ЕVЕ А Vorobyeva
Е А Vorobyeva
GBG Sh Burbaeva
G Sh Burbaeva
To evaluation of glutamate dehydrogenase (GDH) enzymatic activity in platelets of patients with endogenous psychoses. Enzymatic cectivity of GDH evaluated in 69 patients with schizophrenia (n=48) or schizoaffective disorder (n=21) in comparison with control group (n=34) and elucidation of possible link between their platelet GDH activity and clinical psychopathological condition. Generally, GDH activity in patients before antipsychotic treatment was significantly lower, than in control group. Significant differences were revealed in GDH activity before the treatment between subgroups of patients with first episode psychosis (FEP, n=34), chronic patients (n=35), and control group (n=34), wherein GDH activity correlated with PANSS in FEP patients before the treatment course. No links were found in patients with chronic schizophrenia. Besides, significant links between GDH activity determined before the treatment course and PANSS scores after the treatment were found in FEP patients: the higher were levels of platelet GDH activity in FEP patients, the lower were their PANSS scores after the treatment. Initial (baseline) levels of platelet GDH activity can have value for prognosis of antipsychotic pharmacotherapy efficacy in patients with FEP.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
OSO.K. Savushkina
O.K. Savushkina
IBIrina Boksha
Irina Boksha
MOMaria Omel’chenko
Maria Omel’chenko
ETE.B. Tereshkina
E.B. Tereshkina
TPT.A. Prokhorova
T.A. Prokhorova
GBG.Sh. Burbaeva
G.Sh. Burbaeva
ЦЕЛЬ ИССЛЕДОВАНИЯ Выявление клинико-биологических корреляций у пациентов с аттенуированными симптомами шизофрении при первых юношеских депрессиях: корреляций между баллами по шкалам SOPS и HDRS-21 и уровнями активности ферментов глутатионового, глутаматного и энергетического метаболизма в крови пациентов. МАТЕРИАЛ И МЕТОДЫ В исследование были включены юноши (n=81) 16—25 лет с первым депрессивным эпизодом (F32.1, F32.2, F32.38, F32.8), которые были разделены на группы с преобладающими аттенуированными позитивными симптомами (группа 1, n=36) и преобладающими аттенуированными негативными симптомами (группа 2, n=24) и группа без аттенуированных симптомов шизофрении (группа 3, n=21). Контрольную группу составили 20 психически здоровых мужчин 19—25 лет. При обследовании больных наряду с психопатологическими применялись психометрические методы с использованием шкал SOPS и HDRS-21. Активность ферментов цитохром с-оксидазы (ЦО), глутаматдегидрогеназы (ГДГ), глутатионредуктазы (ГР), глутатион-S-трансферазы (ГСТ) в клетках крови определяли спектрофотометрически. РЕЗУЛЬТАТЫ По сравнению с контрольной группой, активность тромбоцитарных ГДГ, ГР и ГСТ (до и после лечения) достоверно снижена в в группах 1, 2, 3 (U-тест Манна—Уитни, p<0,0002, p<0,001 и p<0,0001 соответственно); в группе 1 снижена активность эритроцитарной ГСТ p<0,05, а в группе 3 — эритроцитарных ГР и ГСТ p<0,05. В группе 1 базовый уровень ЦО (до лечения) положительно коррелировал с баллами по SOPS-N после лечения (R=0,580, p=0,0003), а базовый уровень эритроцитарной ГР отрицательно коррелировал с суммой баллов по HDRS-21 после лечения (R=–0,591, p=0,0004). В группе 2 базовый уровень ГДГ положительно коррелировал с баллами, набранными после лечения по SOPS-P (R=0,425, p=0,0384), SOPS-N (R=0,500, p=0,0129), SOPS (R=0,526, p=0,0083) и HDRS-21 (R=0,479, p=0,0180). ЗАКЛЮЧЕНИЕ Обнаружение клинико-биологических корреляций в группах больных с аттенуированными симптомами шизофрении в структуре юношеской депрессии способствует пониманию патогенетических механизмов формирования высокого клинического риска развития психозов и вносит вклад в поиск маркеров инициальных этапов шизофрении.

15 March 2022 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
IBIrina Boksha
Irina Boksha
MOMaria Omel’chenko
Maria Omel’chenko
OSOlga K. Savushkina
Olga K. Savushkina
TPTatyana A. Prokhorova
Tatyana A. Prokhorova
ETElena B. Tereshkina
Elena B. Tereshkina
GBGulnur Sh. Burbaeva
Gulnur Sh. Burbaeva

17 December 2021 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
OSO. K. Savushkina
O. K. Savushkina
ETE. B. Tereshkina
E. B. Tereshkina
TPT. A. Prokhorova
T. A. Prokhorova
IBIrina Boksha
Irina Boksha
TST. P. Safarova
T. P. Safarova
GBG. Sh. Burbaeva
G. Sh. Burbaeva
The aim of the study is to evaluate the activity of platelet glutamate dehydrogenase (GDH) in late-life depression compared to the healthy control group and to reveal possible correlations with clinical data. Patients and methods: 42 elderly patients (60–86 years old) with depressive episodes of different nosological categories according to ICD-10 were examined: a single depressive episode (F32.0, F32.1), a depressive episode in recurrent depressive disorder (RDD — F33.0, F33.1) and a depressive episode in bipolar affective disorder (BD — F31.3). The activity of GDH and the severity of depression (using the Hamilton depressive scale, HAMD-17, and the Hamilton scale for assessing anxiety, HARS) were evaluated twice: before the starting the course of antidepressant therapy (day 0) and on the 28th day of the treatment course. Results: patients showed a significant decrease in the activity of GDH compared to the control group (p < 0.0008). Before the treatment, GDH activity was significantly reduced compared to the control in both RDD and BD (p < 0.002 and p < 0.004), whereas after the treatment, the decreased GDH activity was observed only in patients with BD (p < 0.002). When compared with the control group, male patients showed a significant decrease in GDH activity both before and after the treatment course (p < 0.017 and p < 0.027), whereas women patients showed the decrease only before the treatment (p < 0.014). Conclusion: the decreased platelet GDH activity in elderly depressions may indicate an impairment of glutamate metabolism. Gender differences were revealed in the reversal of GDH activity level after the therapy: in men, the level of GDH activity did not recover to control values after the treatment course. An elevation in the level of GDH to control values over a 28-day course of therapy occurred only in patients with RDD, but not in patients with BD.

30 May 2022 in The European Journal of Psychiatry
Verified
Journal Article
Closed access
OSOlga Savushkina
Olga Savushkina
IBIrina Boksha
Irina Boksha
TPTatyana Prokhorova
Tatyana Prokhorova
ETElena Tereshkina
Elena Tereshkina
TSTatyana Safarova
Tatyana Safarova
GBGulnur Burbaeva
Gulnur Burbaeva